<< Read Full Article
<< Read Full Article
Successful Tarceva Study Sends Shares Skyward
Updated from 10:42 a.m. EDT
How big a cancer drug can Tarceva be?
That's the next question being asked by investors in the wake of a triumphant clinical announcement late Sunday night, which sent related shares soaring Monday. Results from a phase III study, sponsored by OSI Pharmaceuticals (OSIP Quote), showed the experimental drug Tarceva helped patients with advanced non-small cell lung cancer live longer than patients taking a placebo. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,464.40 | 1,110.63 | 2,176.05 | 32.79 |
Oil *
75.60
|
|
UP
30.69
|
UP
4.98
|
UP
6.87
|
DOWN
0.38
|
10 Yr
3.28%
SPDR Gold
116.62
|
|
+0.29%
|
+0.45%
|
+0.32%
|
-1.15%
|
Data delayed 20 minutes |
Connect with TheStreet